Literature DB >> 10703731

Adverse drug reactions to antibiotics and major antibiotic drug interactions.

J Novotný1, M Novotný.   

Abstract

Adverse drug reaction and drug interactions represent negative consequences of pharmacotherapy. A thorough knowledge of how the adverse reactions and drug interactions occur will aid in our ability to provide the best patient care possible. Adverse drug reactions and drug interactions are defined and mechanisms of their occurrence are discussed; ways to identify, assess, manage, and report these reactions are presented. The importance of postmarketing surveillance is highlighted. A thorough understanding of the mechanism of adverse drug reactions and drug interaction is essential for the health care practitioner. Improved patient care can be achieved by applying this knowledge to the individual patient. When drugs are administered to patients, many things can go wrong. The magnitude of this problem warrants spending sufficient resources to establish programs to identify, assess, and manage these reactions. Having effective reporting programs will help prevent many reactions and will provide earlier detection of adverse reactions to new drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10703731

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  5 in total

Review 1.  [Cytochrom-P450 mediated drug interactions caused by antibiotics].

Authors:  Christiane Thallinger; Christian Joukhadar
Journal:  Wien Med Wochenschr       Date:  2006-09

2.  A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital.

Authors:  M Shamna; C Dilip; M Ajmal; P Linu Mohan; C Shinu; C P Jafer; Yahiya Mohammed
Journal:  Saudi Pharm J       Date:  2014-09       Impact factor: 4.330

3.  Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs.

Authors:  L Gallelli; M Colosimo; D Pirritano; M Ferraro; S De Fazio; N M Marigliano; G De Sarro
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

4.  Off-label medicine use in children and adolescents: results of a population-based study in Germany.

Authors:  Hildtraud Knopf; Ingrid-Katharina Wolf; Giselle Sarganas; Wanli Zhuang; Wolfgang Rascher; Antje Neubert
Journal:  BMC Public Health       Date:  2013-07-03       Impact factor: 3.295

Review 5.  Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings.

Authors:  A M Morris; E Rennert-May; B Dalton; N Daneman; L Dresser; S Fanella; J Grant; Y Keynan; N Le Saux; J McDonald; Y Shevchuk; D Thirion; J M Conly
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-29       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.